Our mission is to provide global and local healthcare providers the tools they need to perform both population surveillance and individual diagnosis of pathogens to prevent unnecessary deaths and halt the growing problem of disease drug resistance.

To do this, we are developing highly sensitive and massively multiplex DNA/RNA sequencing-based diagnostics that combine our proprietary QUANTUMProbes technology with Next Generation Sequencing and our ever-expanding FUSIONCloud to bring results directly to the desktop or mobile devices.

The use of FUSION GENOMICS’ reliably rapid, highly sensitive and cost effective ONETest products will advance the field of molecular diagnostics beyond the limitations and shortcomings of molecular assays currently in use.

Our vision is of a world where humans are healthier because diseases are identified faster and treated/cured sooner through the use of assays that employ advanced sequencing technologies.